Leisure Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LACQU and buy or sell other stocks, options, and ETFs commission-free!About LACQU
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses.
CEOD. Lynn Kirkpatrick, PhD
CEOD. Lynn Kirkpatrick, PhD
Employees—
Employees—
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2003
Founded2003
Employees—
Employees—
LACQU Key Statistics
Market cap34.04M
Market cap34.04M
Price-Earnings ratio28.40
Price-Earnings ratio28.40
Dividend yield—
Dividend yield—
Average volume25.10
Average volume25.10
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$22.01
52 Week high$22.01
52 Week low$9.03
52 Week low$9.03